Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dahl

Showing results (101-110 of 232) with videos related to

Pageof 24
Sort By:
Therapeutic Drug Monitoring|January 1, 1982
Plasma and erythrocyte levels of methotrimeprazine and two of its nonpolar metabolites in psychiatric patientsS G Dahl, T Bratlid, O Lingjaerde
Gene|June 9, 1995
Use of alternate promoters for tissue-specific expression of the gene coding for connexin32I M Neuhaus, G Dahl, R Werner
Psychopharmacology Series|January 1, 1993
Molecular modeling of neurotransmitter receptors and ligandsS G Dahl, O Edvardsen, I Sylte
Proteins|September 1, 1996
A database of mutants and effects of site-directed mutagenesis experiments on G protein-coupled receptorsK Kristiansen, S G Dahl, O Edvardsen
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1991
Molecular dynamics of dopamine at the D2 receptorS G Dahl, O Edvardsen, I Sylte
FEBS Letters|August 29, 1994
A connexin-32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytesC Rabadan-Diehl, G Dahl, R Werner
Annals of Medicine|October 10, 2002
Bioinformatics: from genome to drug targetsSvein G Dahl, Kurt Kristiansen, Ingebrigt Sylte
Journal De Physiologie|November 1, 1976
Intracellular membrane junctions during the exocytosis of insulinG Dahl, W Berger, H P Meissner
Protein Engineering|September 1, 1993
Molecular dynamics of the 5-HT1a receptor and ligandsI Sylte, O Edvardsen, S G Dahl
The Journal of Membrane Biology|January 1, 1981
Cell junction and cycle AMP: III. Promotion of junctional membrane permeability and junctional membrane particles in a junction-deficient cell typeR Azarnia, G Dahl, W R Loewenstein
Pageof 24

Showing results (101-110 of 232) with videos related to

Sort By:
Pageof 24
Therapeutic Drug Monitoring|January 1, 1982
Plasma and erythrocyte levels of methotrimeprazine and two of its nonpolar metabolites in psychiatric patientsS G Dahl, T Bratlid, O Lingjaerde
Gene|June 9, 1995
Use of alternate promoters for tissue-specific expression of the gene coding for connexin32I M Neuhaus, G Dahl, R Werner
Psychopharmacology Series|January 1, 1993
Molecular modeling of neurotransmitter receptors and ligandsS G Dahl, O Edvardsen, I Sylte
Proteins|September 1, 1996
A database of mutants and effects of site-directed mutagenesis experiments on G protein-coupled receptorsK Kristiansen, S G Dahl, O Edvardsen
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1991
Molecular dynamics of dopamine at the D2 receptorS G Dahl, O Edvardsen, I Sylte
FEBS Letters|August 29, 1994
A connexin-32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytesC Rabadan-Diehl, G Dahl, R Werner
Annals of Medicine|October 10, 2002
Bioinformatics: from genome to drug targetsSvein G Dahl, Kurt Kristiansen, Ingebrigt Sylte
Journal De Physiologie|November 1, 1976
Intracellular membrane junctions during the exocytosis of insulinG Dahl, W Berger, H P Meissner
Protein Engineering|September 1, 1993
Molecular dynamics of the 5-HT1a receptor and ligandsI Sylte, O Edvardsen, S G Dahl
The Journal of Membrane Biology|January 1, 1981
Cell junction and cycle AMP: III. Promotion of junctional membrane permeability and junctional membrane particles in a junction-deficient cell typeR Azarnia, G Dahl, W R Loewenstein
Pageof 24